Onxeo meets US Investors during “French Life Sciences Days” event in New York on June 17 & 18, 2015
Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), an innovative company specializing in the development of orphan oncology drugs, announced today its participation in the “French Life Sciences Days” to be held in New York on June 17 & 18, 2015.
Initiated by France Biotech, the event “French Life Sciences Days” aims to bring together French Life Sciences companies listed on stock market with the North American financial community. Given the great success of its first edition of June 2014, France Biotech renews this event to enable innovative SMEs to promote their achievements and attractiveness towards specialized US-based investors.
During this event, about 20 French Biotech Medtech and Cleantech, including Onxeo will present and hold face-to-face meetings with specialized North American investment funds, banks, financial analysts. This event will also be widely covered by the medias in France and in the US.
« US investors show a growing level interest in the French Biotech companies’ innovations and breakthroughs. The “Life Sciences Days” event in New York is an excellent opportunity for Onxeo to reinforce its visibility with these specialized US investors, to strengthen their knowledge about recent company’s achievements and future growth strategy ”, comments Judith Greciet, CEO of Onxeo and board member of France Biotech association.
“French Life Sciences Days”, June 18, 2015 - W Hotel, 541 Lexington Avenue, New York, NY 10022, United States